- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Chelsea Therapeutics International Ltd+ Add to Watchlist
CHTP:US5.6700 USD 0.0100 0.18%
As of 20:10:00 ET on 03/07/2014.
Company Profile for Chelsea Therapeutics International Ltd (CHTP)
Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders.
Chelsea Therapeutics International Ltd
Key Executives for Chelsea Therapeutics International Ltd (CHTP)
|Joseph G OlivetoPresident/CEO||Keith W SchmidtChief Commercial Officer|
|William D SchwietermanVP/Chief Medical Officer||L Arthur HewittVP/Chief Scientific Officer|
|J Nick RiehleVP:Administration/CFO||Michael J RobertsVP:Business Development|